Advanced in IgG4-Related Disease

Gunnstein Bakland

Tromso, NO 
Advanced in IgG4-Related Disease
Tromso, NO 
OverviewLocationsClinical Research

Overview

Gunnstein Bakland practices in Tromso, Norway. Bakland is rated as an Advanced expert by MediFind in the treatment of IgG4-Related Disease. Their top areas of expertise are Arthritis, Rheumatoid Arthritis (RA), Ankylosing Spondylitis, and Necrosis.

Their clinical research consists of co-authoring 61 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of IgG4-Related Disease.

Locations

Tromso, Norway

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Aiming to Reduce Disease-related Gastrointestinal Symptoms in Systemic Sclerosis by Repeat Intestinal Infusions of Anaerobic Cultivated Human Intestinal Microbiome (ACHIM); a Randomized, Double-blind Placebo-controlled 20 Week Study
Aiming to Reduce Disease-related Gastrointestinal Symptoms in Systemic Sclerosis by Repeat Intestinal Infusions of Anaerobic Cultivated Human Intestinal Microbiome (ACHIM); a Randomized, Double-blind Placebo-controlled 20 Week Study
Enrollment Status: Completed
Publish Date: October 12, 2022
Intervention Type: Drug
Study Phase: Phase 2
REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design
REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design
Enrollment Status: Completed
Publish Date: April 26, 2022
Intervention Type: Drug
Study Drugs: TNF inhibitors, Synthetic DMARD(s)
Study Phase: Phase 4
View 1 Less Clinical Trial

61 Total Publications

Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Efficacy and safety of microbiota-targeted therapeutics in autoimmune and inflammatory rheumatic diseases: protocol for a systematic review and meta-analysis of randomised controlled trials.
Journal: BMJ open
Published: December 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Bakland's expertise for a condition
ConditionClose
    View All 11 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile